DeepCardio SmartECG is a full-cycle AI solution that predicts the risk of various cardiac diseases using the same standard ECG procedure, supporting clinical decision-making by healthcare professionals.
SmartECG-AF Risk
SmartECG-AF Risk is an AI ECG solution that analyzes normal sinus rhythm (NSR) to predict the likelihood of developing atrial fibrillation.
Standard ECG Test
(10 Seconds)
Since it uses the same ECG procedure already in practice, introducing SmartECG adds no additional workload.
SmartECG AI Analysis
After a standard 10-second 12-lead ECG test, the SmartECG analysis engine processes
the generated digital data (XML) to analyze subtle signal patterns.
AF Risk Probability Result
The analysis result presents the likelihood of
future atrial fibrillation as a probability indicator.
The existing workflow is preserved, meaning there is no additional burden from adding an AI-powered analysis.
SmartECG-AF Risk Analysis
SmartECG-AF Risk is the world's first solution — both domestically and internationally — to use AI to analyze normal-state ECG data and present the risk of developing atrial fibrillation.
Trained on high-quality data from Korea's leading medical institutions, the AI detects subtle signal characteristics within normal ECGs that are imperceptible to the naked eye, presenting the risk of atrial fibrillation as a probability.
Superior Clinical Performance
Clinical Performance: AUC 0.91
*Based on 2024 MFDS approval standards
Multi-Center Research
Developed in collaboration with Korea's leading medical institutions
Medical Device Approval & Ministry of Health Notice
(No. 2024-203)
Designated as Innovative Medical Technology for atrial fibrillation and listed under HIRA's non-reimbursable medical services
SmartECG
Integrated Analysis Results
SmartECG delivers multiple analysis results from a single ECG test, all consolidated in one screen.
Upcoming Analyses to Be Integrated:
sigCAD · ACS · HFmrEF · HCMP · Fabry and more
Products currently under regulatory approval will be integrated into the service sequentially upon completion of required approvals.
SmartECG-AF Risk
Indicator for Likelihood of Atrial Fibrillation
SmartECG-CV Risk
Cardiac Age-Based Cardiovascular Risk Indicator
SmartECG-EF
Indicator for Likelihood of Left Ventricular Ejection Fraction Below 40
Clinical Value
Current Clinical Practice
- Definitive diagnosis requires documented atrial fibrillation (paroxysmal)
on ECG - Early, irregular atrial fibrillation (paroxysmal)
often appears normal during hospital testing - Diagnosis often occurs only after the disease progresses and symptoms become frequent and prolonged — missing the window for timely treatment and prevention
With SmartECG-AF Risk
- Enables early identification of high-risk
AF patients even from normal ECGs - Provides risk information regardless of the timing of the test
- AF Risk results can inform decisions on further testing and follow-up monitoring
- Enables preventive management strategies before symptoms arise
Value of Early AF Screening
By providing an AF likelihood indicator even from normal sinus rhythm (NSR), SmartECG-AF Risk can be used in
hospital and health checkup center settings to identify high-risk patients early.
AI ECG Testing Procedure
ECG Test
Standard 10-second ECG test performed
in outpatient or health checkup settings
AF Risk Analysis & Result Delivery
Review ECG analysis results via PACS/EMR to confirm AF risk probability
Risk Assessment
Identification of patients at high risk
for atrial fibrillation (AFib)
Clinical Decision
Determine need for additional testing or establish a preventive management strategy